Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 10 | 2023 | 1188 | 1.960 |
Why?
|
Lower Extremity | 14 | 2023 | 1158 | 1.720 |
Why?
|
American Heart Association | 9 | 2021 | 1056 | 1.250 |
Why?
|
Advisory Committees | 6 | 2017 | 775 | 1.090 |
Why?
|
Progeria | 7 | 2023 | 185 | 1.040 |
Why?
|
Vasodilation | 20 | 2009 | 944 | 1.020 |
Why?
|
Peripheral Vascular Diseases | 10 | 2017 | 550 | 0.950 |
Why?
|
Cardiology | 8 | 2021 | 1668 | 0.920 |
Why?
|
Brachial Artery | 16 | 2009 | 369 | 0.900 |
Why?
|
Ultrasonography, Doppler | 8 | 2020 | 458 | 0.780 |
Why?
|
Ankle Brachial Index | 3 | 2018 | 154 | 0.750 |
Why?
|
Arteries | 5 | 2020 | 1119 | 0.730 |
Why?
|
Pulmonary Embolism | 7 | 2023 | 2376 | 0.710 |
Why?
|
Disease Management | 5 | 2021 | 2459 | 0.710 |
Why?
|
Societies, Medical | 11 | 2018 | 3743 | 0.670 |
Why?
|
Nitroglycerin | 8 | 2016 | 325 | 0.640 |
Why?
|
Practice Guidelines as Topic | 9 | 2016 | 7279 | 0.630 |
Why?
|
Thromboembolism | 4 | 2016 | 986 | 0.580 |
Why?
|
Endothelium, Vascular | 16 | 2009 | 4456 | 0.540 |
Why?
|
Vascular Diseases | 5 | 2020 | 1161 | 0.480 |
Why?
|
Takayasu Arteritis | 1 | 2015 | 96 | 0.480 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2014 | 110 | 0.460 |
Why?
|
Carotid Arteries | 9 | 2017 | 952 | 0.460 |
Why?
|
Arteriosclerosis | 7 | 2004 | 1092 | 0.450 |
Why?
|
Angina Pectoris | 1 | 2016 | 977 | 0.430 |
Why?
|
Exercise Tolerance | 1 | 2016 | 770 | 0.400 |
Why?
|
Pulmonary Artery | 3 | 2016 | 1912 | 0.390 |
Why?
|
Carotid Stenosis | 6 | 2016 | 854 | 0.390 |
Why?
|
Arterial Occlusive Diseases | 5 | 2008 | 793 | 0.390 |
Why?
|
Peroneal Neuropathies | 1 | 2010 | 20 | 0.370 |
Why?
|
Giant Cell Arteritis | 3 | 2020 | 292 | 0.370 |
Why?
|
Diagnostic Imaging | 9 | 2018 | 3507 | 0.360 |
Why?
|
Ankle | 2 | 2019 | 327 | 0.350 |
Why?
|
Intermittent Claudication | 4 | 2017 | 309 | 0.350 |
Why?
|
Regional Blood Flow | 8 | 2009 | 1525 | 0.340 |
Why?
|
Angiography | 7 | 2020 | 1639 | 0.340 |
Why?
|
Estrogen Replacement Therapy | 5 | 2000 | 1203 | 0.320 |
Why?
|
Leg | 6 | 2020 | 1116 | 0.310 |
Why?
|
Carotid Artery Diseases | 3 | 2011 | 882 | 0.300 |
Why?
|
Femoral Artery | 4 | 2011 | 845 | 0.290 |
Why?
|
Mental Processes | 1 | 2008 | 249 | 0.290 |
Why?
|
Perioperative Care | 4 | 2015 | 1002 | 0.290 |
Why?
|
Radial Artery | 1 | 2008 | 194 | 0.280 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1333 | 0.280 |
Why?
|
Temporal Arteries | 2 | 2017 | 128 | 0.280 |
Why?
|
Veins | 4 | 2020 | 770 | 0.280 |
Why?
|
Blood Vessels | 2 | 2006 | 1125 | 0.280 |
Why?
|
Ultrasonography, Interventional | 6 | 2017 | 1486 | 0.270 |
Why?
|
Pulsatile Flow | 4 | 2012 | 332 | 0.270 |
Why?
|
Aortic Diseases | 3 | 2014 | 742 | 0.260 |
Why?
|
Oscillometry | 1 | 2005 | 147 | 0.260 |
Why?
|
Embolism, Cholesterol | 1 | 2004 | 34 | 0.240 |
Why?
|
Insurance Benefits | 2 | 2016 | 183 | 0.230 |
Why?
|
Venous Thromboembolism | 4 | 2022 | 1671 | 0.230 |
Why?
|
Humans | 117 | 2023 | 744343 | 0.230 |
Why?
|
Magnetic Resonance Angiography | 8 | 2020 | 1442 | 0.230 |
Why?
|
Saphenous Vein | 4 | 2009 | 532 | 0.230 |
Why?
|
Aneurysm, False | 2 | 2006 | 276 | 0.220 |
Why?
|
Blood Pressure | 10 | 2018 | 8554 | 0.220 |
Why?
|
Foot Diseases | 1 | 2004 | 143 | 0.220 |
Why?
|
Exercise | 2 | 2019 | 5615 | 0.220 |
Why?
|
Cardiovascular Diseases | 11 | 2018 | 15165 | 0.210 |
Why?
|
Ischemia | 4 | 2023 | 1907 | 0.210 |
Why?
|
Thoracic Outlet Syndrome | 2 | 2015 | 85 | 0.210 |
Why?
|
Endarterectomy, Carotid | 3 | 2016 | 546 | 0.210 |
Why?
|
Iliac Artery | 2 | 2020 | 364 | 0.200 |
Why?
|
Blood Pressure Determination | 1 | 2005 | 634 | 0.200 |
Why?
|
Stents | 5 | 2016 | 3280 | 0.200 |
Why?
|
Heart Ventricles | 1 | 2014 | 3821 | 0.200 |
Why?
|
Vasomotor System | 2 | 1999 | 209 | 0.190 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2018 | 1186 | 0.190 |
Why?
|
Vascular Patency | 5 | 2010 | 886 | 0.190 |
Why?
|
Aged | 43 | 2023 | 163280 | 0.190 |
Why?
|
Aortography | 2 | 2020 | 437 | 0.190 |
Why?
|
Geriatric Assessment | 1 | 2008 | 1372 | 0.190 |
Why?
|
Retinal Artery Occlusion | 1 | 2021 | 74 | 0.190 |
Why?
|
Estradiol | 4 | 2008 | 2020 | 0.180 |
Why?
|
Retinal Artery | 1 | 2021 | 111 | 0.180 |
Why?
|
Ultrasonography | 12 | 2014 | 5985 | 0.180 |
Why?
|
Coronary Vessels | 5 | 2016 | 3107 | 0.180 |
Why?
|
Gangrene | 3 | 2023 | 82 | 0.180 |
Why?
|
United States | 27 | 2023 | 69872 | 0.180 |
Why?
|
Aortitis | 1 | 2020 | 74 | 0.180 |
Why?
|
Female | 71 | 2023 | 380194 | 0.180 |
Why?
|
Male | 62 | 2023 | 350118 | 0.180 |
Why?
|
Venous Insufficiency | 2 | 2011 | 103 | 0.180 |
Why?
|
Predictive Value of Tests | 13 | 2020 | 15076 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 6 | 2015 | 20129 | 0.170 |
Why?
|
Radiology | 5 | 2017 | 2100 | 0.170 |
Why?
|
Popliteal Artery | 3 | 2009 | 317 | 0.170 |
Why?
|
Venous Thrombosis | 3 | 2020 | 1239 | 0.170 |
Why?
|
Thrombin | 1 | 2001 | 598 | 0.170 |
Why?
|
Hemostatics | 1 | 2001 | 229 | 0.170 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6364 | 0.160 |
Why?
|
Medicare | 8 | 2023 | 6566 | 0.150 |
Why?
|
Middle Aged | 41 | 2020 | 213383 | 0.150 |
Why?
|
Aging | 3 | 2011 | 8664 | 0.150 |
Why?
|
Progesterone | 2 | 1999 | 776 | 0.150 |
Why?
|
Angiography, Digital Subtraction | 2 | 2017 | 341 | 0.150 |
Why?
|
Ultrasonography, Doppler, Duplex | 7 | 2012 | 205 | 0.150 |
Why?
|
Coronary Artery Disease | 5 | 2016 | 6487 | 0.140 |
Why?
|
Inflammation Mediators | 1 | 2005 | 1889 | 0.140 |
Why?
|
Evidence-Based Medicine | 7 | 2018 | 3610 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2104 | 0.140 |
Why?
|
Treatment Outcome | 22 | 2023 | 63114 | 0.140 |
Why?
|
Quality of Life | 2 | 2019 | 12804 | 0.140 |
Why?
|
Piperidines | 2 | 2016 | 1602 | 0.140 |
Why?
|
Exercise Test | 2 | 2018 | 2074 | 0.140 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 643 | 0.130 |
Why?
|
Hypothermia | 1 | 2017 | 189 | 0.130 |
Why?
|
Consensus | 4 | 2020 | 2959 | 0.130 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 100 | 0.130 |
Why?
|
Mentors | 1 | 2020 | 631 | 0.130 |
Why?
|
Verapamil | 1 | 2015 | 244 | 0.130 |
Why?
|
Vitamin E | 1 | 1999 | 869 | 0.130 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 840 | 0.130 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1107 | 0.120 |
Why?
|
Coronary Stenosis | 2 | 2017 | 834 | 0.120 |
Why?
|
Fontan Procedure | 2 | 2011 | 778 | 0.120 |
Why?
|
Pulse | 3 | 2017 | 229 | 0.120 |
Why?
|
Pravastatin | 1 | 2016 | 395 | 0.120 |
Why?
|
Pain | 3 | 2017 | 4986 | 0.120 |
Why?
|
Cognition Disorders | 1 | 2008 | 4043 | 0.120 |
Why?
|
Transplantation Immunology | 1 | 2015 | 546 | 0.110 |
Why?
|
Rest | 1 | 2018 | 901 | 0.110 |
Why?
|
Whole Body Imaging | 1 | 2015 | 280 | 0.110 |
Why?
|
Estrogens | 3 | 2000 | 1566 | 0.110 |
Why?
|
Vascular Resistance | 1 | 1996 | 936 | 0.110 |
Why?
|
Coronary Thrombosis | 1 | 2016 | 495 | 0.110 |
Why?
|
Facial Transplantation | 1 | 2015 | 226 | 0.110 |
Why?
|
Arm | 2 | 2008 | 589 | 0.110 |
Why?
|
Anesthesia, Obstetrical | 1 | 2015 | 235 | 0.110 |
Why?
|
Arteriovenous Fistula | 1 | 2016 | 315 | 0.110 |
Why?
|
Farnesyltranstransferase | 1 | 2012 | 76 | 0.110 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2012 | 26 | 0.110 |
Why?
|
Pyridines | 2 | 2016 | 2825 | 0.110 |
Why?
|
Acute Disease | 5 | 2017 | 7149 | 0.110 |
Why?
|
Risk Factors | 21 | 2023 | 72290 | 0.110 |
Why?
|
Heart Defects, Congenital | 3 | 2023 | 4584 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2018 | 921 | 0.110 |
Why?
|
Health Services Misuse | 1 | 2014 | 243 | 0.110 |
Why?
|
Insulin Resistance | 4 | 2007 | 3864 | 0.110 |
Why?
|
Adult | 31 | 2020 | 214055 | 0.100 |
Why?
|
Ventricular Function, Right | 1 | 2016 | 591 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 906 | 0.100 |
Why?
|
Diphosphonates | 1 | 2016 | 623 | 0.100 |
Why?
|
Glucocorticoids | 2 | 2017 | 2107 | 0.100 |
Why?
|
Syncope | 1 | 2014 | 429 | 0.100 |
Why?
|
Atherosclerosis | 4 | 2010 | 3445 | 0.100 |
Why?
|
Prognosis | 8 | 2020 | 29063 | 0.100 |
Why?
|
Anticoagulants | 4 | 2009 | 4599 | 0.100 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 500 | 0.100 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 789 | 0.100 |
Why?
|
Patient Care Management | 1 | 2014 | 306 | 0.100 |
Why?
|
Nitric Oxide | 6 | 2009 | 2132 | 0.100 |
Why?
|
Myocardium | 2 | 2018 | 4776 | 0.090 |
Why?
|
Stockings, Compression | 1 | 2010 | 37 | 0.090 |
Why?
|
Aorta, Abdominal | 2 | 2012 | 646 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2016 | 581 | 0.090 |
Why?
|
Myocardial Contraction | 1 | 2016 | 1585 | 0.090 |
Why?
|
Pulmonary Veins | 1 | 2016 | 761 | 0.090 |
Why?
|
Blood Flow Velocity | 2 | 2011 | 1423 | 0.090 |
Why?
|
Forearm | 3 | 1997 | 409 | 0.090 |
Why?
|
Imidazoles | 1 | 2016 | 1206 | 0.090 |
Why?
|
Hypesthesia | 1 | 2010 | 109 | 0.090 |
Why?
|
Myocardial Infarction | 4 | 2016 | 11727 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1486 | 0.090 |
Why?
|
Retrospective Studies | 13 | 2023 | 77449 | 0.090 |
Why?
|
Thoracic Injuries | 1 | 2012 | 272 | 0.090 |
Why?
|
Vascular Surgical Procedures | 2 | 2010 | 1475 | 0.090 |
Why?
|
Postmenopause | 3 | 2008 | 2461 | 0.090 |
Why?
|
Enoxaparin | 2 | 2009 | 377 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2004 | 1504 | 0.080 |
Why?
|
Prospective Studies | 14 | 2023 | 53288 | 0.080 |
Why?
|
Stroke | 3 | 2016 | 9981 | 0.080 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2015 | 397 | 0.080 |
Why?
|
Heart | 2 | 2018 | 4467 | 0.080 |
Why?
|
Tropomyosin | 2 | 1985 | 102 | 0.080 |
Why?
|
Enzyme Inhibitors | 5 | 2012 | 3798 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14722 | 0.080 |
Why?
|
Echocardiography | 3 | 2018 | 5102 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 2 | 2012 | 4042 | 0.080 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2015 | 1390 | 0.070 |
Why?
|
Hydrochlorothiazide | 1 | 2007 | 98 | 0.070 |
Why?
|
Hyperemia | 5 | 2009 | 225 | 0.070 |
Why?
|
Cardiovascular System | 1 | 2014 | 832 | 0.070 |
Why?
|
Wrist | 1 | 2008 | 224 | 0.070 |
Why?
|
Manometry | 1 | 2009 | 445 | 0.070 |
Why?
|
Pain Measurement | 1 | 2016 | 3420 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2010 | 549 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1273 | 0.070 |
Why?
|
Plethysmography | 1 | 2006 | 180 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2968 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2013 | 1095 | 0.070 |
Why?
|
Tetralogy of Fallot | 1 | 2011 | 623 | 0.070 |
Why?
|
Posture | 1 | 2010 | 958 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8642 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 1082 | 0.070 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2006 | 233 | 0.070 |
Why?
|
Wounds, Nonpenetrating | 1 | 2012 | 794 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2008 | 940 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3508 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2008 | 1005 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 451 | 0.060 |
Why?
|
Blood Volume | 1 | 2006 | 565 | 0.060 |
Why?
|
Renal Artery | 1 | 2006 | 398 | 0.060 |
Why?
|
Renin-Angiotensin System | 2 | 2007 | 759 | 0.060 |
Why?
|
Drug Therapy, Combination | 4 | 2016 | 6489 | 0.060 |
Why?
|
Peptides | 1 | 2016 | 4409 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9959 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 592 | 0.060 |
Why?
|
Hypertension | 2 | 2018 | 8480 | 0.060 |
Why?
|
Polysaccharides | 2 | 2007 | 1053 | 0.060 |
Why?
|
C-Reactive Protein | 3 | 2020 | 3778 | 0.060 |
Why?
|
Spironolactone | 1 | 2007 | 382 | 0.060 |
Why?
|
Chronic Disease | 2 | 2016 | 9146 | 0.060 |
Why?
|
Accreditation | 1 | 2006 | 450 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2016 | 3670 | 0.060 |
Why?
|
Biphenyl Compounds | 1 | 2008 | 913 | 0.060 |
Why?
|
Contrast Media | 3 | 2012 | 5300 | 0.060 |
Why?
|
Adolescent | 10 | 2018 | 85781 | 0.060 |
Why?
|
Pericardial Effusion | 1 | 2005 | 247 | 0.060 |
Why?
|
Sex Characteristics | 3 | 2023 | 2585 | 0.060 |
Why?
|
Automation | 1 | 2005 | 584 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.060 |
Why?
|
Hand | 1 | 2008 | 884 | 0.060 |
Why?
|
Fingers | 1 | 2006 | 513 | 0.050 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1536 | 0.050 |
Why?
|
General Surgery | 1 | 2014 | 1636 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 707 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2018 | 19905 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2006 | 476 | 0.050 |
Why?
|
Cacao | 1 | 2003 | 98 | 0.050 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2007 | 370 | 0.050 |
Why?
|
Coronary Circulation | 2 | 2007 | 1572 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2016 | 1979 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4397 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Aged, 80 and over | 9 | 2016 | 57776 | 0.050 |
Why?
|
Tetrazoles | 1 | 2008 | 835 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Acetylcholine | 3 | 1999 | 621 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2015 | 6234 | 0.050 |
Why?
|
Follow-Up Studies | 8 | 2016 | 39050 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15540 | 0.050 |
Why?
|
Outpatients | 2 | 2009 | 1486 | 0.050 |
Why?
|
Insulin | 5 | 2008 | 6580 | 0.050 |
Why?
|
District of Columbia | 1 | 2001 | 157 | 0.050 |
Why?
|
Washington | 1 | 2001 | 313 | 0.050 |
Why?
|
Aortic Valve Stenosis | 1 | 2013 | 1965 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2003 | 526 | 0.050 |
Why?
|
Flavonoids | 1 | 2003 | 443 | 0.050 |
Why?
|
Progestins | 2 | 2000 | 306 | 0.050 |
Why?
|
Survival Analysis | 3 | 2015 | 10252 | 0.050 |
Why?
|
Coronary Disease | 3 | 2004 | 6077 | 0.050 |
Why?
|
Limb Salvage | 1 | 2023 | 433 | 0.050 |
Why?
|
Pennsylvania | 1 | 2001 | 613 | 0.050 |
Why?
|
Child, Preschool | 5 | 2018 | 41006 | 0.050 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 984 | 0.040 |
Why?
|
Electrocardiography | 3 | 2018 | 6442 | 0.040 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12959 | 0.040 |
Why?
|
Observer Variation | 3 | 2015 | 2593 | 0.040 |
Why?
|
Secondary Prevention | 2 | 2021 | 1530 | 0.040 |
Why?
|
Foot | 1 | 2023 | 527 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 520 | 0.040 |
Why?
|
Hemodynamics | 2 | 2008 | 4199 | 0.040 |
Why?
|
Vasodilator Agents | 4 | 2009 | 977 | 0.040 |
Why?
|
Injections | 1 | 2001 | 840 | 0.040 |
Why?
|
Cross-Over Studies | 2 | 2007 | 2029 | 0.040 |
Why?
|
Craniotomy | 1 | 2002 | 729 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 8949 | 0.040 |
Why?
|
Beverages | 1 | 2003 | 820 | 0.040 |
Why?
|
Heart Murmurs | 1 | 2018 | 94 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2008 | 2046 | 0.040 |
Why?
|
Coronary Artery Bypass | 2 | 2017 | 2289 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2012 | 3327 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.040 |
Why?
|
Warfarin | 1 | 2006 | 1496 | 0.040 |
Why?
|
Neoplasms | 2 | 2023 | 21683 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2004 | 1133 | 0.040 |
Why?
|
Homocystine | 1 | 1997 | 22 | 0.040 |
Why?
|
Fertilization | 1 | 2018 | 196 | 0.040 |
Why?
|
Blood Platelets | 2 | 1985 | 2508 | 0.040 |
Why?
|
Stress, Mechanical | 2 | 2016 | 1686 | 0.040 |
Why?
|
Subclavian Artery | 1 | 2017 | 130 | 0.040 |
Why?
|
Monitoring, Physiologic | 2 | 2015 | 1738 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4567 | 0.040 |
Why?
|
Time Factors | 6 | 2016 | 40075 | 0.040 |
Why?
|
Adipose Tissue | 2 | 2006 | 3279 | 0.040 |
Why?
|
Wound Healing | 1 | 2008 | 2785 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1676 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2012 | 4933 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10397 | 0.040 |
Why?
|
Protein Prenylation | 1 | 2016 | 73 | 0.040 |
Why?
|
Cohort Studies | 7 | 2015 | 40561 | 0.030 |
Why?
|
Methylprednisolone | 1 | 2017 | 387 | 0.030 |
Why?
|
Aneurysm | 1 | 1999 | 339 | 0.030 |
Why?
|
Triglycerides | 2 | 2004 | 2454 | 0.030 |
Why?
|
Biopsy | 2 | 2017 | 6756 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2005 | 3200 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2012 | 10943 | 0.030 |
Why?
|
Anastomosis, Surgical | 3 | 2008 | 987 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 680 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2008 | 6993 | 0.030 |
Why?
|
Inflammation | 2 | 2020 | 10638 | 0.030 |
Why?
|
Cholesterol | 3 | 1999 | 2917 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3251 | 0.030 |
Why?
|
omega-N-Methylarginine | 2 | 2009 | 111 | 0.030 |
Why?
|
Emergencies | 1 | 2021 | 1170 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2006 | 255 | 0.030 |
Why?
|
Carrier Proteins | 2 | 1985 | 5021 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1261 | 0.030 |
Why?
|
Peripartum Period | 1 | 2015 | 133 | 0.030 |
Why?
|
Reference Values | 4 | 2007 | 4982 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2006 | 2291 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2003 | 1889 | 0.030 |
Why?
|
Child | 5 | 2018 | 77709 | 0.030 |
Why?
|
Age Factors | 4 | 2015 | 18370 | 0.030 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2018 | 482 | 0.030 |
Why?
|
Triage | 1 | 2021 | 976 | 0.030 |
Why?
|
Program Development | 1 | 2020 | 1316 | 0.030 |
Why?
|
Boston | 2 | 2010 | 9313 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4420 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2006 | 2872 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.030 |
Why?
|
Registries | 2 | 2022 | 8089 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2225 | 0.030 |
Why?
|
Homocysteine | 1 | 1997 | 647 | 0.030 |
Why?
|
Aorta | 1 | 2021 | 2061 | 0.030 |
Why?
|
Tunica Intima | 1 | 2015 | 464 | 0.030 |
Why?
|
Curriculum | 1 | 2006 | 3605 | 0.030 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 641 | 0.030 |
Why?
|
Professional Practice | 1 | 2015 | 326 | 0.030 |
Why?
|
Elasticity | 2 | 2006 | 657 | 0.030 |
Why?
|
Anesthesia, Epidural | 1 | 2015 | 228 | 0.030 |
Why?
|
Risk Assessment | 3 | 2016 | 23338 | 0.030 |
Why?
|
Prednisone | 1 | 2017 | 1574 | 0.030 |
Why?
|
Surgical Procedures, Operative | 2 | 2015 | 1876 | 0.030 |
Why?
|
Potassium | 2 | 2007 | 1336 | 0.030 |
Why?
|
Fentanyl | 1 | 2015 | 410 | 0.030 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 238 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7659 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 1996 | 651 | 0.030 |
Why?
|
Blood Glucose | 4 | 2008 | 6256 | 0.030 |
Why?
|
Palpation | 1 | 2012 | 167 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 2015 | 417 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2000 | 2187 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 10900 | 0.030 |
Why?
|
Transplantation, Autologous | 3 | 2004 | 2124 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2016 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2009 | 2274 | 0.030 |
Why?
|
Serum Albumin | 2 | 1985 | 676 | 0.030 |
Why?
|
Program Evaluation | 1 | 2020 | 2488 | 0.030 |
Why?
|
Meglumine | 1 | 2012 | 149 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.020 |
Why?
|
Renin | 2 | 2007 | 642 | 0.020 |
Why?
|
Kidney | 1 | 2007 | 7186 | 0.020 |
Why?
|
Survival Rate | 1 | 2005 | 12788 | 0.020 |
Why?
|
Lipoprotein(a) | 1 | 1995 | 435 | 0.020 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12245 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 1995 | 712 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2016 | 1206 | 0.020 |
Why?
|
Drug-Eluting Stents | 1 | 2017 | 753 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 1995 | 638 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 681 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2645 | 0.020 |
Why?
|
Double-Blind Method | 3 | 2002 | 12026 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 935 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16365 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2008 | 35421 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 2002 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2110 | 0.020 |
Why?
|
Life Tables | 2 | 2000 | 370 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.020 |
Why?
|
Lamin Type A | 1 | 2010 | 190 | 0.020 |
Why?
|
Vomiting | 1 | 2012 | 636 | 0.020 |
Why?
|
Delphi Technique | 1 | 2012 | 778 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1781 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2021 | 1917 | 0.020 |
Why?
|
Aldosterone | 2 | 2008 | 877 | 0.020 |
Why?
|
Odds Ratio | 2 | 2016 | 9849 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 1998 | 2356 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2250 | 0.020 |
Why?
|
India | 2 | 2006 | 2197 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13284 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 836 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2012 | 665 | 0.020 |
Why?
|
Antioxidants | 1 | 1996 | 1663 | 0.020 |
Why?
|
Adaptation, Physiological | 2 | 2008 | 1312 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 25043 | 0.020 |
Why?
|
Upper Extremity | 1 | 2012 | 648 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.020 |
Why?
|
Chromatography, Affinity | 2 | 1985 | 549 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13989 | 0.020 |
Why?
|
Catecholamines | 1 | 2008 | 387 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2013 | 1063 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2009 | 21746 | 0.020 |
Why?
|
Menopause | 1 | 1994 | 1626 | 0.020 |
Why?
|
Administration, Sublingual | 1 | 2006 | 56 | 0.020 |
Why?
|
Factor X | 1 | 2006 | 64 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2009 | 689 | 0.020 |
Why?
|
Renal Circulation | 1 | 2007 | 333 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2007 | 666 | 0.020 |
Why?
|
Young Adult | 2 | 2011 | 56430 | 0.020 |
Why?
|
Hemorrhage | 2 | 2009 | 3461 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2007 | 11725 | 0.020 |
Why?
|
Administration, Oral | 2 | 2009 | 3913 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2008 | 440 | 0.020 |
Why?
|
Growth | 1 | 2008 | 376 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2006 | 266 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2017 | 4577 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1985 | 1801 | 0.020 |
Why?
|
Cause of Death | 1 | 2016 | 3584 | 0.020 |
Why?
|
Phenylephrine | 1 | 2006 | 301 | 0.020 |
Why?
|
Bone and Bones | 1 | 2016 | 2575 | 0.020 |
Why?
|
Pericardiocentesis | 1 | 2005 | 74 | 0.020 |
Why?
|
Diarrhea | 1 | 2012 | 1348 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6538 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 1985 | 181 | 0.020 |
Why?
|
Lipids | 2 | 2007 | 3305 | 0.020 |
Why?
|
Fatigue | 1 | 2012 | 1531 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 1985 | 668 | 0.020 |
Why?
|
Pilot Projects | 2 | 2007 | 8324 | 0.020 |
Why?
|
Actinin | 1 | 1985 | 160 | 0.010 |
Why?
|
Renal Dialysis | 1 | 2013 | 1786 | 0.010 |
Why?
|
Subcutaneous Tissue | 1 | 2004 | 135 | 0.010 |
Why?
|
Sodium Chloride | 1 | 2006 | 625 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.010 |
Why?
|
Gravity Suits | 1 | 2002 | 12 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4215 | 0.010 |
Why?
|
Albuminuria | 1 | 2007 | 682 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2006 | 916 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2013 | 2266 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2004 | 402 | 0.010 |
Why?
|
Molecular Weight | 1 | 1985 | 2255 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2006 | 642 | 0.010 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2004 | 235 | 0.010 |
Why?
|
Sodium | 1 | 2008 | 1623 | 0.010 |
Why?
|
Weight Gain | 1 | 2012 | 2292 | 0.010 |
Why?
|
Creatinine | 1 | 2008 | 1919 | 0.010 |
Why?
|
Rabbits | 2 | 1985 | 4894 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2212 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
Brain | 1 | 2008 | 26385 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2002 | 8863 | 0.010 |
Why?
|
Systole | 1 | 2003 | 958 | 0.010 |
Why?
|
Diastole | 1 | 2003 | 791 | 0.010 |
Why?
|
Artifacts | 1 | 2010 | 1904 | 0.010 |
Why?
|
Solubility | 1 | 2003 | 1085 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13408 | 0.010 |
Why?
|
Bandages | 1 | 2002 | 266 | 0.010 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2007 | 924 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2009 | 1179 | 0.010 |
Why?
|
Infant | 2 | 2016 | 35136 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10388 | 0.010 |
Why?
|
Inguinal Canal | 1 | 2000 | 69 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1518 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2018 | 15295 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7913 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2004 | 885 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7729 | 0.010 |
Why?
|
Administration, Intravaginal | 1 | 1999 | 150 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 1999 | 176 | 0.010 |
Why?
|
Analysis of Variance | 2 | 1999 | 6365 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1590 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2003 | 1155 | 0.010 |
Why?
|
Amino Acids | 1 | 1985 | 1736 | 0.010 |
Why?
|
Adiponectin | 1 | 2004 | 1100 | 0.010 |
Why?
|
Abdomen | 1 | 2004 | 1118 | 0.010 |
Why?
|
Women's Health | 1 | 2008 | 2034 | 0.010 |
Why?
|
Prevalence | 1 | 1995 | 15226 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5078 | 0.010 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 1999 | 236 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 1999 | 711 | 0.010 |
Why?
|
Nitroprusside | 1 | 1996 | 275 | 0.010 |
Why?
|
Cold Temperature | 1 | 1999 | 772 | 0.010 |
Why?
|
Heparin | 1 | 2002 | 1637 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 2951 | 0.010 |
Why?
|
Animals | 4 | 2000 | 168757 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29144 | 0.010 |
Why?
|
Radiography | 1 | 2004 | 7023 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2002 | 2158 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 3336 | 0.010 |
Why?
|
Glucose | 1 | 2003 | 4397 | 0.010 |
Why?
|
Linear Models | 1 | 2000 | 5952 | 0.010 |
Why?
|
Proteins | 1 | 2004 | 6103 | 0.010 |
Why?
|
Body Weight | 1 | 1999 | 4669 | 0.000 |
Why?
|
Regression Analysis | 1 | 1997 | 6459 | 0.000 |
Why?
|
Immunosorbent Techniques | 1 | 1985 | 184 | 0.000 |
Why?
|
Testosterone | 1 | 1995 | 2420 | 0.000 |
Why?
|
Trypsin | 1 | 1985 | 511 | 0.000 |
Why?
|
Cross Reactions | 1 | 1985 | 841 | 0.000 |
Why?
|
Body Mass Index | 1 | 1999 | 12720 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1985 | 13815 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1985 | 5097 | 0.000 |
Why?
|